Kestra Medical Technologies, Ltd. shows strong sales growth but faces significant operating losses and a concerning slowdown in sequential revenue growth. Despite a large addressable market and innovative cardiac device, the company's one-product focus and high valuation amplify risks. Recent quarters reveal only modest revenue increases, casting doubt on the sustainability of Kestra's growth trajectory post-IPO.
KIRKLAND, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future KIRKLAND, Wash., May 13, 2025 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) announced the finalists for the Entrepreneur Of The Year 2025 Mountain West Award.
2 Apr 2025 Date | | - Cons. EPS | - EPS |
2 Apr 2025 Date | | - Cons. EPS | - EPS |